UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$575.00 USD
-2.07 (-0.36%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $575.31 +0.31 (0.05%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for UnitedHealth Group Incorporated falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 23,144.00 | 20,639.00 | 17,732.00 | 15,769.00 | 14,239.00 |
Depreciation/Amortization & Depletion | 3,972.00 | 3,400.00 | 3,103.00 | 2,891.00 | 2,720.00 |
Net Change from Assets/Liabilities | 1,643.00 | 2,246.00 | 1,522.00 | 2,895.00 | 683.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 309.00 | -79.00 | -14.00 | 619.00 | 821.00 |
Net Cash From Operating Activities | 29,068.00 | 26,206.00 | 22,343.00 | 22,174.00 | 18,463.00 |
Property & Equipment | -3,386.00 | -2,802.00 | -2,454.00 | -2,051.00 | -2,071.00 |
Acquisition/ Disposition of Subsidiaries | -9,451.00 | -18,044.00 | -4,821.00 | -7,139.00 | -8,343.00 |
Investments | -1,777.00 | -6,837.00 | -1,843.00 | -2,836.00 | -2,504.00 |
Other Investing Activities | -960.00 | -793.00 | -1,254.00 | -506.00 | 219.00 |
Net Cash from Investing Activities | -15,574.00 | -28,476.00 | -10,372.00 | -12,532.00 | -12,699.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -6,647.00 | -5,747.00 | -3,645.00 | -2,810.00 | -4,463.00 |
Issuance (Repayment) of Debt | 4,280.00 | 12,536.00 | 2,481.00 | 2,586.00 | 3,994.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -6,761.00 | -5,991.00 | -5,280.00 | -4,584.00 | -3,932.00 |
Other Financing Activities | -2,401.00 | 3,428.00 | -1,011.00 | 1,218.00 | -1,224.00 |
Net Cash from Financing Activities | -11,529.00 | 4,226.00 | -7,455.00 | -3,590.00 | -5,625.00 |
Effect of Exchange Rate Changes | 97.00 | 34.00 | -62.00 | -116.00 | -20.00 |
Net Change In Cash & Equivalents | 2,062.00 | 1,990.00 | 4,454.00 | 5,936.00 | 119.00 |
Cash at Beginning of Period | 23,365.00 | 21,375.00 | 16,921.00 | 10,985.00 | 10,866.00 |
Cash at End of Period | 25,427.00 | 23,365.00 | 21,375.00 | 16,921.00 | 10,985.00 |
Diluted Net EPS | 23.86 | 21.18 | 18.08 | 16.03 | 14.33 |
Fiscal Year End for UnitedHealth Group Incorporated falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3,200.00 | -1,221.00 | 23,144.00 | 17,469.00 | 11,431.00 |
Depreciation/Amortization & Depletion | 2,017.00 | 997.00 | 3,972.00 | 2,998.00 | 1,991.00 |
Net Change from Assets/Liabilities | -6,333.00 | -6,242.00 | 1,643.00 | 13,496.00 | 13,906.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 9,006.00 | 7,610.00 | 309.00 | 298.00 | 31.00 |
Net Cash From Operating Activities | 7,890.00 | 1,144.00 | 29,068.00 | 34,261.00 | 27,359.00 |
Property & Equipment | -1,596.00 | -743.00 | -3,386.00 | -2,427.00 | -1,589.00 |
Acquisition/ Disposition of Subsidiaries | -3,031.00 | -3,006.00 | -9,451.00 | -8,389.00 | -8,161.00 |
Investments | -221.00 | 492.00 | -1,777.00 | -2,850.00 | -1,574.00 |
Other Investing Activities | -8,909.00 | -3,083.00 | -960.00 | -721.00 | -424.00 |
Net Cash from Investing Activities | -13,757.00 | -6,340.00 | -15,574.00 | -14,387.00 | -11,748.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2,328.00 | -2,586.00 | -6,647.00 | -5,461.00 | -4,372.00 |
Issuance (Repayment) of Debt | 12,790.00 | 11,364.00 | 4,280.00 | 5,848.00 | 7,695.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -3,664.00 | -1,729.00 | -6,761.00 | -5,023.00 | -3,284.00 |
Other Financing Activities | 237.00 | 1,182.00 | -2,401.00 | 263.00 | 2,692.00 |
Net Cash from Financing Activities | 7,035.00 | 8,231.00 | -11,529.00 | -4,373.00 | 2,731.00 |
Effect of Exchange Rate Changes | -309.00 | -48.00 | 97.00 | 49.00 | 106.00 |
Net Change In Cash & Equivalents | 859.00 | 2,987.00 | 2,062.00 | 15,550.00 | 18,448.00 |
Cash at Beginning of Period | 25,427.00 | 25,427.00 | 23,365.00 | 23,365.00 | 23,365.00 |
Cash at End of Period | 26,286.00 | 28,414.00 | 25,427.00 | 38,915.00 | 41,813.00 |
Diluted Net EPS | 4.54 | -1.53 | 5.85 | 6.24 | 5.82 |